• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hemophilia

Hemophilia - 100 Studies Found

Active, not recruiting : Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
: Hemophilia B
: 2015-03-04
: Genetic: AAV5-hFIX AAV5hFIX gene therapy Other Name:
Completed : Study of Biostate® in Children With Hemophilia A
: Hemophilia A
: 2010-10-01
: Biological: Biostate 1 dose of 50 IU FVIII/kg body weight of Biostate administered intravenously on Day
Completed : Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia
: Hemophilia
: 2014-02-15
:
  • Biological: Cellular therapy b

Completed : Hemophilia Inhibitor Genetics Study (HIGS)
: Hemophilia A With Inhibitor
: 2005-09-09
: Procedure: Blood draw A single blood draw. Other Nam
Active, not recruiting : National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
: Hemophilia A
: 2015-07-17
: Behavioral: Educational Package Patients will be invited to attend a PK educational session as part of t
Completed : Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
: Hemophilia A
: 2006-07-25
:
  • Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)

Completed : Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
: Hemophilia A
: 2005-10-20
: Biological: ReFacto AF
Completed : A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors
: Hemophilia A
: 2016-07-26
: Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u
Completed : Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
: Hemophilia A
: 2012-03-22
: Drug: GreenGene Dose : 10 ~ 50IU/kg Administration method : intravenous infusion or bolus
Enrolling by invitation : Platelet Function in Patients With Hemophilia A
: Hemophilia A
: 2014-03-19
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.